MEDICATION ASSISTED TREATMENT REQUEST FOR BUPRENORPHINE/NALOXONE > 24MG PER DAY Complete ENTIRE form and Fax to: 866-940-7328 SECTION 1: Identification of Client and Providers Last name First name Middle initial Address Phone number ( ) Physician Name Member ID City State ZIP Code If release is for information about dependent child(ren), name(s) of dependent child(ren) NPI Number Physician’s Address Physician’s phone number ( ) State ZIP Code City SECTION 2: Patient Authorization for Disclosure of Confidential Information The above-named patient hereby authorizes the following entities to exchange and disclose to one another information concerning the patient’s name and other personal identifying information, their status as a patient, diagnosis, recommended medication(s) and the treatment recommendation(s): • The Health Care Authority (HCA) • Any Managed Care Organization (MCO) contracted by HCA to provide your medical care • The above named physician. The purpose of this authorization for disclosure is: • To initiate an authorization to obtain a prescription and coordinate care. I understand that my alcohol and/or drug treatment records are protected under Federal and State confidentiality regulations governing Confidentiality of Alcohol and Drug Abuse Patient Records, 42 Code of Federal Regulations (CFR) Part 2, and the Health Insurance Portability and Accountability Act of 1996 (HIPAA), 45 CFR Parts 160 and 164, and cannot be disclosed without my written consent unless otherwise provided for in the regulations. I also understand that I may revoke this consent at any time except to the extent that action has been taken in reliance on it, and that in any event this consent expires automatically as follows: six (6) months from the date signed or the following specific date, event, or condition upon which this consent expires: Patient Signature Date Guardian or Authorized Representative Signature (if required) Date SECTION 3: To be completed by prescriber only Patient has been unable to maintain abstinence form other opioids at a dose of 24mg/ day? □ Yes □ No If Yes, supporting documentation such as urine drug tests must be submitted with this request. Has the patient complied with scheduled visits and requests to return for pill counts? □Yes □ No Has the patient complied with provision of urine samples as requested? □Yes □ No Has the patient complied with all other treatment requirements you have set for them? □Yes □ No Urine drug tests show the presence of buprenorphine and its metabolite? □Yes □ No If Yes to all of the above, attach supporting labs, chart notes, and treatment records. If the duration of treatment will be greater than six months, I understand that I must complete form HCA 13-333, Medication Assisted Treatment Patient Status every six months and retain in the members medical records. The form can be found at http://www.hca.wa.gov/medicaid/pharmacy/Pages/ffs_drug_criteria.aspx. Prescriber signature Prescriber specialty Date Notice Prohibiting Redisclosure of Alcohol or Drug Treatment Information This information has been disclosed to you from records protected by Federal confidentiality rules (42 CFR part 2). The Federal rules prohibit you from making any further disclosure of this information unless further disclosure is expressly permitted by the written consent of the person to whom it pertains or as otherwise permitted by 42 CFR part 2. A general authorization for the release of medial or other information is NOT sufficient for this purpose. The Federal rules restrict any use of the information to criminally investigate or prosecute any alcohol or drug abuse patient. Prescribing Medication Assisted Treatment (MAT) Prescribers Authorization is required for UnitedHealthcare Community Plan members to receive some MAT products. Please see Pharmacy Program and Formulary Information at http://www.uhccommunityplan.com for a listing of medications and authorization requirements. To request authorization for your patient to receive MAT: A. Go to Pharmacy Program and Formulary Information at http://www.uhccommunityplan.com B. Determine whether the drug you will be prescribing requires authorization: o If no: Client may receive the product without further authorization requirement. For treatment that will o exceed six months, please see ‘ongoing treatment’ below. If yes: Select the Medication Assisted Treatment Request form for the drug or dose you will be prescribing. Both you and your patient must complete and sign this form. Fax the completed form to the Pharmacy Prior Authorization unit at 866-940-7328. For ongoing treatment beyond six months: • If treatment continues for longer than six months, you must complete form HCA 13-333 Medication Assisted Treatment Patient Status form every six months and maintain it in the patient’s records for later audit and review by Health Care Authority. • The requirement to complete and maintain the Medication Assisted Treatment Patient Status applies to all MAT, including those not requiring prior authorization. Form HCA 13-333 can be found at the Washington Health Care Authority website.
© Copyright 2018 AnyForm